Core One Labs Inc
Company Profile
Business description
Core One Labs Inc is a psychedelic research and development life sciences enterprise focused on bringing psychedelic medicines to market through novel delivery systems and psychedelic assisted psychotherapy. The company intends to further develop and apply the technology to psychedelic compounds, such as psilocybin. The Company operates a virtual clinic that assesses patients for the appropriateness of treatment plans for the use of medical cannabis to treat their symptoms. The Company partners with physicians and Health Canada’s licensed producers for the provision of treatments, fulfillment of prescriptions, and sale of related products.
Contact
1199 West Hastings Street
Suite 800
VancouverBCV6E 3T5
CANT: +1 236 521-0626
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
31 December 2025
Employees
Stocks News & Analysis
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,524.80 | 55.10 | -0.64% |
| CAC 40 | 7,883.63 | 3.06 | -0.04% |
| DAX 40 | 23,934.98 | 167.55 | 0.70% |
| Dow JONES (US) | 42,792.07 | 137.33 | 0.32% |
| FTSE 100 | 8,699.31 | 14.75 | 0.17% |
| HKSE | 23,332.72 | 12.33 | -0.05% |
| NASDAQ | 19,215.46 | 4.36 | 0.02% |
| Nikkei 225 | 37,498.63 | 255.09 | -0.68% |
| NZX 50 Index | 12,629.07 | 157.72 | -1.23% |
| S&P 500 | 5,963.60 | 5.22 | 0.09% |
| S&P/ASX 200 | 8,295.10 | 48.60 | -0.58% |
| SSE Composite Index | 3,367.58 | 0.12 | 0.00% |